Results 181 to 190 of about 9,399,207 (308)

Assessment of combined α-GAL enzyme activity and lyso-GL3 for Fabry disease screening in women with chronic kidney disease

Cassiano Augusto Braga Silva, Fellype Carvalho Barreto, Osvaldo Merege Vieira Neto, Leandro Júnior Lucca, Fernando A. Vieira, Ana Paula Santana Gueiros, Marta V. Boger, Artur Quintiliano Silva, Felipe Leite Guedes, Karla Cristina Petruccelli Israel, Gina Elizabeth Moreno Gordon, Valéria Soares Pigozzi Veloso, Gabriela Sevignani, Carolina Teles Barretto, Maria Gabriela Rosa, Roberta Correa Pascotto, Gelzie S. Ennes, Eduarda Morgana da Silva Montenegro Malaguti Souza, Márcia Gonçalves Ribeiro, Luís Gustavo Modelli de Andrade   +19 more
openalex   +1 more source

In reply—Strategies of Screening for Fabry Disease in Patients With Unexplained Left Ventricular Hypertrophy [PDF]

, 2019
Darrell B. Newman, Michael J. Ackerman
openalex   +1 more source

Perivascular spaces and basilar artery remodeling in Fabry disease-a dual vascular pathology. [PDF]

Front Neurol
Roh J, Cheon CK, Lee SY, Baik SK, Park MG, Park KP, Ahn SH.   +6 more
europepmc   +1 more source

An Asymptomatic Heterozygous Female with Fabry Disease: Implications for Enzyme Replacement Therapy

, 2005
Shinichiro Inagaki, Makoto Migita, Mari Hayakawa, Atushi Fujita, Junko Yoshida, Masamichi Ishizaki, Masaharu Kotani, Hitoshi Sakuraba, Takashi Shimada, Mutsumi Murakami, Yoshitaka Fukunaga   +10 more
openalex   +2 more sources

Fabry disease: Enfermedad de fabry

, 2018
RESUMEN La enfermedad de Fabry es una enfermedad de depósito lisosomal causada por la deficiencia de la enzima alfa galactosidasa A, con patrón de herencia ligado al cromosoma X. El cuadro clínico tiene una variedad de síntomas y signos; y se han descrito una variante clínica clásica y variantes clínica no clásica como la renal o cardíaca.
openaire   +1 more source

Variable clinical features in patients with Fabry disease

, 2017
Daisy Tapia, Kathy Hall, Jousef Alandy-Dy, Margaret Knight, Dawn Lombardo, Madeleine V. Pahl, Virginia Kimonis   +6 more
openalex   +2 more sources

The insidious degeneration of white matter and cognitive decline in Fabry disease. [PDF]

PLoS One
Johnson JW, Baradaran H, Morgan J, Odèen H, Friel E, Bailey C, Zielinski BA, Underhill HR.   +7 more
europepmc   +1 more source

Parapelvic Cysts: A Suspicious Feature of Fabry Disease

, 2017
Livia Maria Sorrentino, Luigi Annicchiarico Petruzzelli, Angela Maria Pellegrino, Cristina Marchetiello, Maria Amicone, Eleonora Riccio, Antonio Pisani   +6 more
openalex   +1 more source

Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study.

Journal of the American Society of Nephrology, 2017
M. Arends, C. Wanner, D. Hughes, A. Mehta, D. Oder, O. Watkinson, P. Elliott, G. Linthorst, F. Wijburg, M. Biegstraaten, C. Hollak   +10 more
semanticscholar   +1 more source

Renoprotective effects of SGLT2 inhibitors in patients with Fabry disease. [PDF]

Mol Genet Metab Rep
Okamoto H, Goto S, Fujita M, Fujii H.
europepmc   +1 more source